Patent directory · USPTO A61K / A61P
Patents matching “AXIS”
72 pharma patents match "AXIS" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 72 pharmaceutical patents matching "AXIS" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12404297
Salts and crystal forms of GABA-A positive allosteric modulator
granted -
US 12325711
3-(ethoxydifluoromethyl)-6-(5-fluoro-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)-[1,2,4]triazolo[4,3-α]pyrazine as an ion channel modulator
granted -
US 12259378
Dynamic clamps and methods of use thereof
granted -
US 12145939
Substituted [1,2,4]triazolo[4,3-a]pyrazines as ion channel modulators
granted -
US 12077502
Formulations of T-type calcium channel modulators and methods of use thereof
granted -
US 11918571
Compounds and their methods of use
granted -
US 11919836
Prodrugs of fencamfamine
granted -
US 11872200
GABA agonists in the treatment of disorders associated with metabolic syndrome and GABA combinations in treatment or prophylaxis of type I diabetes
granted -
US 11866439
Ion channel modulators
granted -
US 11780821
Inhibitors of fibroblast activation protein
granted -
US 11767325
Substituted [1,2,4]triazolo[4,3-a]pyrazines as ion channel modulators
granted -
US 11731978
3-(ethoxydifluoromethyl)-6-(5-fluoro-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)-[1,2,4]triazolo[4,3-a]pyridine as an ion channel modulator
granted -
US 11731966
Compounds and their methods of use
granted -
US 11731976
3-(ethoxydifluoromethyl)-6-(5-fluoro-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)-[1,2,4]triazolo[4,3-a]pyridine as an ion channel modulator
granted -
US 11697669
Hemi-citrate salts of GABA-A positive allosteric modulator and crystalline form thereof
granted -
US 11649207
Formulations of T-type calcium channel modulators and methods of use thereof
granted -
US 11629146
Substituted [1,2,4]triazolo[4,3-a]pyrazines as modulators of sodium channel activity
granted -
US 11504364
Inhibitors of fibroblast activation protein
granted -
US 11492345
Compounds and their methods of use
granted -
US 11427540
Formulations of T-type calcium channel modulators and methods of use thereof
granted -
US 11400123
Combination product for prophylaxis and treatment of irritable bowel syndrome
granted -
US 11365180
Resolution method for axis chiral enantiomers of lesinurad
granted -
US 11318133
Modulators of integrated stress response pathway
granted -
US 11278535
Compounds and their methods of use
granted